A Better Future for Surplus

Corporate Blog

News & Expert Commentary on Surplus Management

Latest Posts

How Biopharmaceutical Companies Can Innovate More and Protect Profits

Success in the biopharmaceuticals industry comes down to continually developing new and useful pharmaceuticals. Even the most innovative products will eventually see their patents expire and...

Surplus Asset Management Critical for Biopharmaceutical M&A

The biopharmaceuticals industry is in a constant state of flux as a result of the frequency of innovations in this sector, and companies need to keep pace with these changes if they want to...

The Booming Biopharma Used Equipment Market

Over time the secondary market for pharmaceutical equipment has become much larger as organizations have become more comfortable selling their surplus and buyers have become more accepting of...

Best Practices for Surplus Lab Equipment

In order to make money, an organization must be innovative on how to save money. According to an article written by one of our Liquidity Services’ experts and an Executive Vice-President, Tom...

Liquidity Services Article on the State of the Used Equipment Market in BioPharm International

Liquidity Services executive Tom Burton opens his article on the state of the used equipment market, published earlier this month in BioPharm International, with a clear market summary: “Mainstream...

Liquidity Services Shares the Secret to Maximizing Return and Minimizing Risk When Closing a Lab

Closing a lab can be a daunting task for large and small pharmaceutical companies alike. Due to a lack of effective planning, unrealistic timelines, and inaccurate inventory records and market...

Liquidity Services Answers the Question: Redeploy or Sell Assets for the Pharmaceutical Industry?

The pharmaceutical industry has a number of factors impacting its business and continues to adapt their operations to meet business goals. While R&D, manufacturing, and sales and marketing efforts...